Ausgabe 3/2013
Inhalt (15 Artikel)
The Place of GLP-1–Based Therapy in Diabetes Management: Differences Between DPP-4 Inhibitors and GLP-1 Receptor Agonists
Dara L. Eckerle Mize, Marzieh Salehi
Risk vs Benefit in Diabetes Pharmacotherapy: a Rational Approach to Choosing Pharmacotherapy in Type 2 Diabetes
Mary Elizabeth Cox, Mark N. Feinglos
The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
Hanford Yau, Kathya Rivera, Romina Lomonaco, Kenneth Cusi
Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN Trial
Markolf Hanefeld, Peter Bramlage
Is the Risk and Nature of CVD the Same in Type 1 and Type 2 Diabetes?
Lindsey Duca, Rachel Sippl, Janet K. Snell-Bergeon
Nuclear Factor (Erythroid-Derived 2)-Like-2 Factor (Nrf2), a Key Regulator of the Antioxidant Response to Protect Against Atherosclerosis and Nonalcoholic Steatohepatitis
Anisha A. Gupte, Christopher J. Lyon, Willa A. Hsueh
Exercise and Diabetes-Related Cardiovascular Disease: Systematic Review of Published Evidence from Observational Studies and Clinical Trials
Robert W. Koivula, Åsa B. Tornberg, Paul W. Franks
Do Statins Cause Diabetes?
Mark R. Goldstein, Luca Mascitelli
Vascular Calcification in Diabetes: Mechanisms and Implications
Janet K. Snell-Bergeon, Matthew J. Budoff, John E. Hokanson
Hyperglycemia and Vascular Metabolic Memory: Truth or Fiction?
Cristina Bianchi, Roberto Miccoli, Stefano Del Prato
Diabetes Mellitus and Osteoporosis
Robert Sealand, Christie Razavi, Robert A. Adler
Diabetes and HIV: Current Understanding and Future Perspectives
Sanjay Kalra, Navneet Agrawal
Diabetes and Infections-Hepatitis C: Is There Type 2 Diabetes Excess in Hepatitis C Infection?
Cho Naing, Joon Wah Mak, Nyunt Wai, Mala Maung
Diabetes Mellitus and Inflammation
Eric Lontchi-Yimagou, Eugene Sobngwi, Tandi E. Matsha, Andre Pascal Kengne
Diabetes Mellitus and Periodontal Diseases
Corneliu Sima, Michael Glogauer